Antiplasmodial Compounds from Eurycoma harmandiana Pierre and Eurycoma longifolia Jack Against Drug-Resistant Plasmodium falciparum: An Integrated In Vitro and In Silico Study
Authors:
- Atthaphon KonyaneeAtthaphon Konyanee
- Habibah A. WahabHWHabibah A. Wahab
- Ezatul Ezleen KamarulzamanEKEzatul Ezleen Kamarulzaman
- Ahmad Marwazi Mohd SuhaimiASAhmad Marwazi Mohd Suhaimi
- Ahmad Ghazali IsmailAIAhmad Ghazali Ismail
- Prapaporn ChaniadPCPrapaporn Chaniad
- Walaiporn PliratWPWalaiporn Plirat
- Arisara PhuwajaroanpongAPArisara Phuwajaroanpong
- Thaweesak JuengwatanatrakulTJThaweesak Juengwatanatrakul
- Tripetch KanchanapoomTKTripetch Kanchanapoom
- Gorawit YusakulGYGorawit Yusakul
- Chuchard PunsawadCPChuchard Punsawad
Open Access
- 4 September 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7892
Abstract
Malaria is a life-threatening global disease, and despite artemisinin-based combination therapies (ACTs) as first-line treatment, emerging drug-resistant Plasmodium strains necessitate novel antimalarial agents. This study investigated the antiplasmodial potential of Eurycoma harmandiana Pierre (EH) root extract, a medicinal plant closely related to Eurycoma longifolia Jack (EL). The extract and its derived compounds were evaluated using in vitro antiplasmodial and cytotoxicity assays. The active compounds were further investigated by parasite morphological analysis, molecular docking against quadruple-mutant Plasmodium falciparum dihydrofolate reductase (qmPfDHFR), molecular dynamics (MD) simulations, and in silico prediction of drug-likeness, pharmacokinetic properties, and toxicity. The ethanolic extract exhibited potent antiplasmodial activity (IC50 = 0.51 µg/mL) with low cytotoxicity (CC50 = 31.68 µg/mL) and a high selectivity index (SI = 62.11). Quassinoids showed the strongest activity (IC50 = 0.13–0.87 µM), whereas alkaloids displayed good to moderate activity. The extract and two promising bioactive quassinoids, eurycomanone (1) and glaucarubolone (5), disrupted intraerythrocytic parasite development. Molecular docking and MD simulations demonstrated that glaucarubolone (5) exhibited favorable predicted interactions with qmPfDHFR, along with favorable predicted drug-like properties, pharmacokinetic profiles, and low toxicity. This study provides the first report of the antiplasmodial activity of Eurycoma harmandiana, highlighting it as a promising alternative source of bioactive compounds against Plasmodium parasites. Glaucarubolone (5) may represent a promising scaffold for further investigation toward the development of novel antimalarial agents.Keywords
Funding Information
- Walailak University (WU68259)
- Walailak University (WU-CIA-06407/2025)
This publication has 88 references indexed in Scilit:
- Microwave synthesis and antimalarial screening of novel 4-amino benzoic acid (PABA)-substituted pyrimidine derivatives as Plasmodium falciparum dihydrofolate reductase inhibitors3 Biotech, 2022
- Phosphodiesterase‐5 Inhibitory Activity of Canthin‐6‐One Alkaloids and the Roots ofEurycoma longifoliaandEurycoma harmandianaChemistry & Biodiversity, 2022
- Plants as Sources of Natural and Recombinant Antimalaria AgentsMolecular Biotechnology, 2022
- An Allosteric Inhibitory Potential of Triterpenes from Combretum racemosum on the Structural and Functional Dynamics of Plasmodium falciparum Lactate Dehydrogenase Binding LandscapeChemistry & Biodiversity, 2022
- Production of eurycomanone and polysaccharides through adventitious root culture of Eurycoma longifolia in a bioreactorBiochemical Engineering Journal, 2021
- Synthesis, characterization and antimalarial activity of isoquinoline derivativesMedicinal Chemistry Research, 2020
- MolProbity: More and better reference data for improved all‐atom structure validationProtein Science, 2017
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Exploring the folate pathway in Plasmodium falciparumActa Tropica, 2005
- In vittro studies on the mode of action of quassinoids with activity against chloroquine-resistant Plasmodium falciparumBiochemical Pharmacology, 1989